Monday, November 03, 2025 12:32:19 PM
“I know some like to reference masks as a failure but its not; setback(?) maybe but not failure.” A SETBACK???!!! This is literally what everyone says, you’re incapable of having a shred of objectivity. Never seen anyone like you, fckin incredible
Looks like I was wrong on it even being a setback. It actually looks like the whole ordeal with O2 was actually a proof of concept collab that was intended to "fail" so the real collab could go on behind the scenes. Meanwhile "everyone" says the O2 & masks ordeal was a failure which I believe to be purposeful misrepresentation. Considering the evidence now, the whole "failure" rhetoric seems like people trying to con me and others which helped Anson and its conspiracy of funds heavily short SINT from 2H22 to 1H24. But I was the one not being objective...lol.
Dont agree with complete failure at all. In fact things just keep improving on the business front. I know some like to reference masks as a failure but its not; setback(?) maybe but not failure. IP has been developed further, thats a good thing and the IP is unencumbered for future collaborations.
I was incorrect in my statement of "future" collabs. There was already one or more collabs in place!
WHEN the mask thing first was announced I DID think this had great potential but then it fizzled; Bal raised decent funds 3x off of it, and went silent as usual afterwards. All that did was make me think even moreso, that he wasn't THAT serious about getting products to market in any timely manner, if at all....and here we are today.
Bal wasnt completely silent. There were Press Releases, two presentations in 2022/2024, and 10k's all that indicated that Bal was serious about getting masks to market, albeit certainly not timely and not with O2. The study mentioned in this press release was only recently published 4 years after they conducted the study. Meaning Sintx sat on and waited to publish it for years on purpose which aided the whole "failure" & "fizzle" narrative.
During recent months, research at the University of Rochester and at Virginia Polytechnic Institute and State University (Virginia Tech) has confirmed the earlier findings
In its testing, the Company found a consistent 3- to 4-log reduction (>99.9%) in viral loads; this occurred in less than 30 minutes, and in most cases, in less than 5 minutes. Nonwoven polypropylene fabrics embedded with both AP2 and AP4 silicon nitride powders were also effective against the newer SARS-CoV-2 variants, when tested to ISO 18184 standards.
Here is mention of new partners in regards to PPE:
SINTX has maintained a focus on the key target markets for PPE, such as automotive air cabin filters, coatings, and surfaces, and continues to identify other new applications. Because of the early stage of discussions and non-disclosure agreements, SINTX cannot disclose specific partners in some cases.
O2 collab "failure" (intentional) opened the door for this:
New opportunities in protective face masks and mask filters have come forward given the recent announcement to reassess the relationship with O2TODAY.
By March 2022 Sintx presentation indicated a confidential partnership in regards to PPE was already in place:
Quote Souces:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173996951
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173984699
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173147078
https://www.globenewswire.com/news-release/2021/08/18/2282785/30038/en/SINTX-Technologies-Provides-Update-on-Antipathogenic-Business-Segment.html
https://web.archive.org/web/20220327020051/https://4320147.fs1.hubspotusercontent-na1.net/hubfs/4320147/sintx/412073%20-%20SINTX%20Corporate%20Overview%20-%20R4.pdf
https://investorshub.advfn.com/Bostons-research-43724
Could it be that there is a strategy to distract people away from looking at basic data?
Is it an exercise to create forum verbiage to drown out any serious discussion of evidence?
Recent SINT News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 01:02:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/10/2026 01:00:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/19/2026 02:00:04 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/18/2026 01:35:38 PM
- SINTX Technologies Appoints Ryan Elmore President to Lead Channel Expansion of Silicon Nitride Biomaterial Platforms • GlobeNewswire Inc. • 02/18/2026 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/11/2026 01:45:54 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/11/2026 01:44:43 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/11/2026 01:43:48 AM
- SINTX Technologies to Participate in Noble Capital Markets’ Emerging Growth Virtual Equity Conference on February 4–5 • GlobeNewswire Inc. • 01/29/2026 02:00:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 12/12/2025 05:15:20 AM
- Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 12/09/2025 10:01:07 PM
- Sidoti Events, LLC's Year-End Virtual Investor Conference • ACCESS Newswire • 12/09/2025 05:48:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/09/2025 01:00:05 PM
- SINTX Technologies to Participate in Sidoti & Company Investor Conference • GlobeNewswire Inc. • 12/08/2025 02:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/08/2025 01:00:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/01/2025 01:35:26 PM
- SINTX Technologies Signs Supply Agreement with EVONIK to Manufacture Silicon Nitride–PEEK Compound for AI-Assisted, 3D-Printed Patient-Specific Implants • GlobeNewswire Inc. • 12/01/2025 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2025 01:05:43 PM
- SINTX Reports Pivotal Third Quarter Business Update and Financial Highlights Driven by FDA Clearance, Product and IP Portfolio Expansions and Increased Operational Efficiencies • GlobeNewswire Inc. • 11/13/2025 01:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/12/2025 09:17:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/10/2025 01:00:06 PM
- SINTX Technologies Announces Launch of OsseoSculpt™ an Advanced Biologic for Use with SINAPTIC® Foot & Ankle Osteotomy Wedge System • GlobeNewswire Inc. • 11/03/2025 01:00:00 PM
Advances in Domestic Heavy Rare Earth Minerals Production Essential for North American Defense Stockpiles • ALOY • Mar 18, 2026 9:00 AM
ECGI Advances $10M Mortgage Tokenization Pilot as SEC Interpretation Adds Clarity • ECGI • Mar 18, 2026 8:45 AM
ECGI Advances Mortgage Tokenization Pilot as Institutional Market Rails Continue to Develop • ECGI • Mar 17, 2026 8:30 AM
Record Gold Prices Reshape Economics of New Mine Development • SNWGF • Mar 16, 2026 10:46 AM
Cannabix Technologies Announces Commercial Launch of Marijuana Breath Test (MBT) • BLOZF • Mar 16, 2026 8:37 AM
Exxe Group Advances Platform Strategy and Share Structure Reduction Following Strategic Meetings • AXXA • Mar 11, 2026 1:03 PM
